Prognosis of Failure Treatment of Amebic Liver Abscess

Prognosis Factors of the Response After Medical Treatment of Amebic Liver Abscess

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00641992

Enrollment

Registered

2008-03-24

Start date

1999-05-31

Completion date

2000-04-30

Last updated

2008-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amebic Liver Abscess

Keywords

amebic liver abscess, failure, prognosis

Brief summary

Amebic liver abscess is the most frequent extra-intestinal form of the amoebiasis; actually the factors for predicting failure in the medical treatment are not clear. We conducted trial for determining the clinical value of paraclinical factor in this issue.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. Clinical, ultrasonographic and serologic diagnosis (ELISA) of amebic liver abscess. 2. Both genders 3. Older 15 years

Exclusion criteria

1. Clinically suspected piogenous liver abscess 2. Positive hemoculture 3. Negative ELISA for amoebic antigens 4. Immunosupresion (HIV) 5. Abdominal or biliary surgery antecedents 6. Abdominal neoplasia antecedents

Design outcomes

Primary

Measure	Time frame
Failure of medical treatment	Day 4

Countries

Mexico

Outcome results